chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had been feeling dizzy the day after the vaccine; Then 2 weeks after vaccination, passed out in the shower; Became conscious again, and crawled to the toilet to throw up; His pupils were dilated and he had a hard time seeing; Called 911 and was taken to the ER, and was given an EKG along with lab work.
Developed fever 101-103 within 12 hours of Fluzone. Seen 3 days later. Diagnosed viral pharyngitis. Seen again on day 7/10/12/05, with erythema and swelling of M-P joints 2-5 in both hands. DX'd with acute arthritis, possibly lymes W/- serology. Had strep throat x 2 on 3/30/06. and on 4/11/06 TX'd amoxil and Duricef respectively, but on 4/11/06 was noted to have HR 52. EKG complete heart block, admitted to hospital cardiac pacemaker placed. Note EKG at birth was normal sinus rhythm. Discharge summary states bradycardia, fever, heart block. msv
Menstrual cycle began 3 days after vaccine and 4 days after cycle stopped. Heavy bleeding and cramps. Bleeding is abnormal and heavy clotting
Information has been received from a pharmacist via a field representative concerning multiple patients of unknown ages and genders. The pharmacist reported that on unspecified dates multiple patients were vaccinated with unfilled vials of the ZOSTAVAX, subcutaneously; therefore, receiving incorrect dosages of the vaccine. No adverse events were reported. Additional information has been requested.
extra dose administered; Sore arm; Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (extra dose administered), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 mg. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 mg. On 25-Feb-2021, the patient experienced ACCIDENTAL OVERDOSE (extra dose administered), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever). On 25-Feb-2021, ACCIDENTAL OVERDOSE (extra dose administered) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include blood pressure medication for blood pressure management. Patient was advised not to take a third dose. Patient has taken two Aleve and then went to bed.
Muscles: Burning and stiffness, legs, arms, overall ache, especially at night. Joint: Stiff/arthritic feeling and difficulty walking. Breathing: Labored; general fatigue and pain over chest area and under arms/mentally disoriented. I went to Urgent Care on 12/13/00 and the doctor prescribed Ativan so that I could sleep (the pain is overwhelming just turning over) and was told to maximize my nutrition and reduce my stress levels. I have transferred to a different clinic but cannot be seen until 1/4/01 because of HMO regulations. Mentally, I become confused easily, especially with numbers and dates and I have noticed that I wobble when I walk. Up to now, my health and mental attitude have been very good.
Minor soreness 1-2 days after the vaccination, then 9 days after left upper arm swollen, red measuring 4 x 4 inches with white center about half-dollar size. Low grade fever. Diagnosed with allergic reaction. Also has pain and unable to move arm away from side more than 4 inches.
mild fatigue; headache; injection site soreness; Severe joint and soft tissue pain in left foot; Severe joint and soft tissue; This is a spontaneous report from a contactable Consumer. A 62-year-old female non-pregnant patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution of injection, Lot Number: EW0158) via an unspecified route of administration, administered in left arm on 13Apr2021 10:00 (at the age of 62 years old) as dose 1, single for COVID-19 immunization. The patient medical history included osteoarthritis, hypothyroidism, asthma, keratoconus and Cogan's dystrophy from an unknown date and unknown if ongoing. The patient had known allergies: Sulfa from an unknown date. The patient was not diagnosed with COVID prior vaccination. The patient was not tested COVID post vaccination. The patient did not receive other vaccine in four weeks and did not receive prior vaccine. The patient concomitant medications included Fluoxetine (ALZAC [FLUOXETINE]) and Levothyroxine, from an unspecified date for an unspecified indication. On 14Apr2021 6:00, the patient experienced mild fatigue, headache, injection site soreness, severe joint and soft tissue pain in left foot and severe joint and soft tissue. The reporter reported that affected big toe and next two toes/ball of foot/arch and pain was moderate today. The patient did not receive any treatment for the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Patient was admitted to facility admitted as observation on 11/24/21 with acute respiratory failure with hypoxia due to COVID. Patient is currently on 2L of oxygen. Patient was tested for COVID-19 and was positive on 11/22/21.
This initial non-serious spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult male patient of unspecified age. This refers to 12 of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (TIV) Thiomersal (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in a cooler with ice packs for 6 days and had reached unknown temperature during transport (explicitly considered as incorrect product storage) instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient (explicitly considered as drug administration error). The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination. The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
Patient came in said her arm was red and swollen from shoulder to elbow joint. The arm was hard to raise and she couldn't extend it.
Patient reports feeling light pressure on her throat. Patient reports symptoms resolved in 10-15 minutes. Cleared by EMS
Approximately 5-10 minutes after receiving the vaccine, patient began sweating, feeling dizzy and dry heaving. BP was normal as well as HR. This has happened before with vaccines and other needle sticks like blood draws. Patient was given and ice pack to help her cool down and after about 10-15 more minutes, patient was calm enough to leave the vaccine observation area.
SWELLING OF FACE; FATIGUE; HEADACHE; RASH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, treatment medications included: ibuprofen. On 13-MAR-2021, the subject experienced swelling of face. On 13-MAR-2021, the subject experienced fatigue. On 13-MAR-2021, the subject experienced headache. On 13-MAR-2021, the subject experienced rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swelling of face, rash, fatigue, and headache. This report was non-serious.
Around 12:30, patient came in for her FIRST Pfizer COVID-19 vaccine.  About 5 minutes after (Pharmacist) gave the patient the vaccine, patient told pharmacist she had is having "side effects".  pharmacist promptly move the patient from the 15 minute waiting area to the consultation room.  Upon patient siting down, the patient passed out for a few minutes.  After the patient woke up, pharmacist asked if she could state her name and where she was at. Patient was able to answer both question correctly.  After another few minutes, Patient started to throw up and state that she is having shortness of breath.  At this point, the warehouse manager was called and came over  AND one of the pharmacy technician called 911.  When the paramedic arrived, the patient was still having shortness of breath and still throwing up.  A few minutes later the patient was taken with the paramedic to the hospital.  Pt also did mentioned to pharmacist that she did not eat this morning.
Information has been received from a manager of a pharmaceutical wholesaler from a sales representative concerning a patient who was "recently" vaccinated with a dose of Pneumovax 23 (lot # 651319/1007P).  Subsequently the patient experienced "swelling that turned purple" and was also itchy, at the injection site.  Unspecified medical attention was sought.  Additional information has been requested.
borderline crazy; This is a spontaneous report from a contactable consumer (Patient). A 92-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL8982) via an unspecified route of administration in Arm Left on an Unspecified date in Jan2021 as single dose for covid-19 immunisation. Patient did not take other vaccine within 4 weeks prior of vaccination. Medical history included and concomitant medications. The patient experienced borderline crazy. The patient underwent lab tests which included weight: pounds is close enough. The outcome of the event was unknown.
RESTING HEART RATE 110-120 FOR APPROXIMATELY 24 HOURS, BEGINNING 12 HOURS AFTER DOSE
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 74-year-old female patient who received SHINGRIX for prophylaxis. On 14th December 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On 14th December 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema and injection site inflammation. On 15th December 2018, the patient experienced nausea and fever. On 16th December 2018, the outcome of the injection site erythema, nausea, fever and injection site inflammation were recovered/resolved. It was unknown if the reporter considered the injection site erythema, nausea, fever and injection site inflammation to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the right arm. After receiving SHINGRIX, the patient experienced redness and inflammation at injection site. Next day, she experienced fever of 100 degrees F and nausea. All symptoms were resolved. She never had any type of reaction to vaccines in the past. Batch number was not provided. The reporter did gave consent to follow up.
I had a rash on my right foot. This has gone on for weeks now. There are itchy, painful sores and they just won't go away. They are treating me for Shingles, but I don't know if it is Shingles or not. I can't tell if the medication is helping or not because I know that the process of healing from Shingles takes time. I was prescribed valacyclovir and mupirocin.
Inappropriate schedule of vaccine /first dose around two years ago and has not received the second dose yet.; This case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received around two years ago of reporting date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The physician reported inappropriate schedule of Shingrix vaccine. The patient had not received the 2nd dose of Shingrix till the time of reporting, which led to incomplete course of vaccination. The reporter emailed to ask if Shingrix series needs to be restarted if first dose of Shingrix given 2 years prior.  No information on the patient affected by inappropriate schedule of Shingrix vaccine. The reporter consented to follow up.
I forgot to get the second shot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 9th January 2023).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: I forgot to get the second shot). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 04-AUG-2023 This case was reported by a consumer via (Shingrix GSK) interactive digital media. The patient forgot to get the second shot of Shingrix before 6 months or 9th July 2023 but he/she did have that okay. The CDC had provided guidance that if it had been more than 6 months since a patient received the first dose, they should get the do not need to restart the vaccine series. However, the efficacy of alternative dosing regimens had not been evaluated. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Night of 3/30 - headache.  3/31 - severe headache, nausea. Low grade temp (99.4) in the p.m. (Took 2 Tylenol max.)  4/1 - Started with a few itchy dots on stomach. Quickly spread to neck and arms. Continued to legs & feet. Was told to get a Covid test & take Benadryl. (Took 2 Benadryl.)  4/2 - Got negative Covid test results. Rash getting worse. More small, bright pink dots. Saw doctor. Adding 1 extra Zyrtec in the evening, and Pepcid max strength. Pepcid has immediate results reducing the rash. But it still comes back.  Today, 4/4, it is greatly reduced, but varies throughout the day. Some mild, occasional joint pain.
3/3/21: 8:00PM development of fever (100.4F), chills, headache and slight abdominal pain 10 PM. In addition to listed symptoms numbness in feet develops and abdominal pain worsens; treatment with acetaminophen 11:30 PM. Fever of 100.8F; severe URQ/ULQ abdominal pain; moderate chest pain; treatment with oxycodone. Also joint pain in shoulders and wrists (clears after a few hours) 3/4/21: 1 AM. Chest pain and abdominal pain and numbness in feet persist, while dizziness and migraine develop; treatment with 2.5 mg Zolmitriptan 6 AM. Moderate abdominal pain. Treatment with oxycodone 7:30 AM extreme dizziness develops rendering me unable to walk or stand 8:30 AM: temperature 99.8F rest of day: abdominal pain persists
This case was reported by a consumer via call center representative and described the occurrence of tendonitis in a 81-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included ADVIL. On 17th October 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 17th October 2018, immediately after receiving SHINGRIX, the patient experienced pain in arm. On 19th October 2018, the patient experienced tendonitis. On an unknown date, the outcome of the tendonitis and pain in arm were not recovered/not resolved. It was unknown if the reporter considered the tendonitis and pain in arm to be related to SHINGRIX. Additional information received as follows: The patient's concomitant product included Amivok. The patient received SHINGRIX on the left arm. The patient reported that she experienced a sore arm after receiving the dose of SHINGRIX but it was not terrible. By Friday, she had extreme tendinitis in both hands but it was worse in the left hand than the right hand. She could not use her left hand at all. The tendinitis was in her wrists and between her fingers on both hands. The patient also had injection site pain immediately and the injection site was sore to the touch after the shot. The tendinitis started on Friday evening and then she woke up Saturday morning and it was full blown. She was wondering if it could be related to her new migraine injection medication which was considered an immunosuppressant therapy. She had tried to soak her hand and had tried to cool and heat the area and nothing would resolved the tendinitis.
Swelling, redness, warmth within 1 minute of vaccine administration. Improved after 25 mg BENADRYL given and ice pack to site.
Information has been received from a Licensed Practical nurse regarding a patient of unknown age and gender. On unknown date the patient received a dose of VARIVAX (Merck), lot # K007784 and expiration date on 28-MAY-2016, that were exposed to temperatures outside of the proper storage. No adverse effect reported. It was unknown in the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
1st dose June 2019, 2nd never administered; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included SHINGRIX (1st dose received in Jun 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 09-Aug-2022 Reporter's Comments: The case was received from the patient via interactive digital media. The patient had the first dose of Shingrix In June 2019 but never had the second dose. The patient was asking he/she protected just with one dose or not. Additional Supportive Information: Till the time of reporting the patient did not received the second dose of Shingrix, which led to incomplete course of vaccination. Follow-up could not be possible as no contact details were available.
My son started to have blood in his stool when we got home so I sent photos to his doctor. By their recommendation I watched him for a couple days and upon no improvement I brought him in to be seen. I told them I believed it was from the Rotovirus vaccine drink and they wrote me off. They told me to stop breastfeeding and feed him hypoallergenic formula. I refused. I eliminated dairy from my diet and after about a month the bloody diapers stopped. I reintroduced dairy and have not had the problem again.
Patient received the vaccine at 4:00p. Her mother called us over at 4:05 as Shaelynn was feeling "weird".  She began to itch and cough, apparently trying to throw up, felt her throat was itching and swollen. She stated she couldn't swallow and was having a hard time breathing (although she was breathing). We administered an Epi Pen 0.3mg (only one) and called 911. Patient was transported to the hospital by ambulance.
mild fatigue an hour after shot that last for under an hour. moderate soreness at injection sight that presented about an hour after shot and dissipated by the morning.
Patient got 2nd shot and 10 minutes after started feeling sick, nausea, chills and sweating said fell like blood pressure dropping. Paramedics were called in and she left with them.
THROAT SWELLED UP; SWOLLEN UVULA; ACHINESS; SWOLLEN ADENOIDS; HEADACHE; TEMPERATURE OF 102; NUMB ON LEFT SIDE (THROAT); NUMB ON LEFT SIDE (ARM); This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included COVID-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 in total administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.   The patient was hospitalized twice on 07-APR-2021 and on 09-APR-2021 from receiving the vaccine. The patient's throat swelled up and uvula and adenoids completely swelled as per computerised tomogram (CAT) scan. The patient had horrendous achiness and headache that was so much worse than when the patient had COVID a year prior to this report. The patient also had a temperature of 102 that the patient also never had during COVID. The patient was numb on left side (throat and arm) as of 14-APR-2021 which was eight days later. Laboratory data included: Body temperature (NR: not provided) 102 (units unspecified), and CAT scan (NR: not provided) uvula and adenoids completely swelled. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from numb on left side (arm), and numb on left side (throat), and the outcome of throat swelled up, swollen uvula, achiness, headache, temperature of 102 and swollen adenoids was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V.0: 20210432171-covid-19 vaccine ad26.cov2.s-throat swelled up, swollen uvula, achiness and swollen adenoid. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events. 20210432171-covid-19 vaccine ad26.cov2.s-headache, temperature of 102. These events are labeled per RSI and are therefore considered potentially related.
6 hours after vaccine, increasing pain at injection site. At 3 am awoken by muscle spasms, fever, shivering, heart racing, severe headache
I have lost almost 25 pounds, severe tension/pain headache in lower base of skull, extreme fatigue.
Information has been received from a physician, allergist, concerning a 68 year old male patient who never had chicken pox nor the chicken pox vaccine prior to being vaccinated with ZOSTAVAX (Merck) and was vaccinated with a dose of ZOSTAVAX (Merck) (Lot#: not reported) at his primary healthcare professional office 2 years ago, in JUN 2008. The physician reported that the patient presented with shingles rash on 03-JUN-2010, on right side of abdomen extending on the flank and lower back. Lesions were crusted and neurologic pain persisted. The patient was on VALTREX and his outcome was not recovered. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
Angioedema, joint swelling, myalgias, "tight-chest", fever 102 & rash; given meds; 5th dose will not be given; exposed to an unvaxed dog who is thought to be well @ this time; titer will be checked in 3-6 mos;
Had gout issue but it got worse and went to see my doctor and after a physical advised to continue medications. Was advised if gout got worse to come back.